Phaarmasia Limited (BOM:523620)
India · Delayed Price · Currency is INR 98.74
-0.49 (-0.49%)
At close: Jul 6, 2026
Phaarmasia Market Cap
Phaarmasia has a market cap or net worth of 677.37 million as of July 8, 2026. Its market cap has increased by 230.73% in one year.
Market Cap
677.37M
Enterprise Value
578.74M
Revenue
472.08M
Ranking
n/a
PE Ratio
3.85
Stock Price
98.74
Market Cap Chart
Since April 13, 1998, Phaarmasia's market cap has increased from 13.70M to 677.37M, an increase of 4,843.52%. That is a compound annual growth rate of 14.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 674.09M | -12.42% |
| Dec 31, 2025 | 769.67M | 132.45% |
| Dec 31, 2024 | 331.11M | 23.19% |
| Dec 29, 2023 | 268.78M | 41.36% |
| Dec 30, 2022 | 190.13M | -15.73% |
| Dec 31, 2021 | 225.63M | -8.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mercury Laboratories | 954.00M |
| Godavari Drugs | 933.41M |
| Makers Laboratories | 893.61M |
| Amwill Health Care | 832.15M |
| Source Natural Foods and Herbal Supplements | 765.03M |
| Onyx Biotec | 750.67M |
| Asston Pharmaceuticals | 629.70M |
| Biofil Chemicals and Pharmaceuticals | 553.96M |